← Back to all development cases
This case was judged by an anonymized AI reviewer and has not been independently reviewed by people; inspect the draft, cards, and both outputs to assess it.
AutocompleteAbout the same19 / 280 · beu-96af02341f1500b1

Large Language Models in Bioinformatics: A Survey

Quantitative biology · 2503.04490v3

FLOWING EVIDENCE BENCHMARK

How do we compare writing with and without cards?

At the same writing position, the same model produces one first result with cards and one without. All 280 pairs enter the overall anonymized review, which assesses whether a decision not to continue fits the draft.

Overall: 138 with-card wins, 26 ties, 107 no-card wins, 5 pairs where neither was usable, and 4 inconclusive judgments. Both sides wrote text in 218 pairs; 48 had a deliberate stop and 14 included an invalid output.

SAME DRAFT · WITH OR WITHOUT CARDS

01 · FIXED WRITING POSITION

MANUSCRIPT

Same writing position ▌

Matched autocomplete at the same draft position

02 · TWO MATCHED VERSIONS

SHARED BY BOTH

Draft, writing task, and generation model

A · With cards

Relevant literature cards supplied

B · Without cards

No literature cards supplied

Generation model

Same model and version

A → first output

B → first output

Anonymized AI judge

First outputs are anonymized as X and Y

Continuation review: accuracy, fit to the writing task and usability
Returns: X preferred / tie / Y preferred / both unusable

Review again with the answer order swapped

HOW DOES BLIND JUDGING WORK?

① Anonymize both outputs
The AI judge sees the same draft and both first outputs without knowing which received cards.

② Compare and swap order
The judge applies task-specific criteria in X/Y and then Y/X order.

③ Review disagreements
A third pass resolves disagreements. Incomplete reviews remain in the denominator.

How are positions and cards selected?

We selected 40 writing positions in each of seven fields, for 280 comparisons. The position and relevant literature cards were set before each comparison, so both versions began from the same draft.

The main result retains every frozen position, including places where cards might not add a useful next move. This avoids selecting cases based on their outputs, but 49% describes the whole cohort, not a win rate where evidence clearly had an opportunity to help. This cohort did not record that opportunity label for each position before generation, so those two groups cannot yet be separated reliably.

CARD USE · 140/280

Reported card use in continuations with text

The model reports whether a card affected its continuation. In 140 of 280 tests it produced continuation text and reported card use. The previous count of 150 included 10 cases without continuation text and has been corrected.

COMPARISON · 70 / 7 / 30

Which written version was better?

Of the 107 reported-use cases where both versions produced text, the blinded AI judge preferred the with-card version 70 times, found 7 about the same, and preferred the without-card version 30 times.

How are the two table percentages calculated?

ADOPTION COVERAGE

140reported use with text
÷
280all positions
=
50%

WITH-CARD VERSION PREFERRED

70with cards better
÷
107comparable tests
=
65%

The percentages use different groups: 50% counts continuations with text reporting card use among all 280 tests; 65% covers the 107 such cases with text on both sides. The generating model reports card use, while an anonymized AI judge compares writing quality.

Card use is self-reported by the generator. The anonymized AI judge sees the draft and source snippets, so source-aware preference remains possible; there was no independent human review. The overall result describes these 280 frozen positions, not a win probability for any writing task.

Manuscript writing position

Text excerpt · not a PDF page

Research manuscript · excerpt

Large Language Models in Bioinformatics: A Survey

7 Conclusions and Future Directions

Foundation models like scBERT Yang et al. 2022 , and scGPT Cui et al. 2024 have transformed single-cell data analysis through self-supervised pretraining on millions of transcriptomes, enabling robust transfer learning for tasks such as cell annotation, perturbation prediction, and batch correction. Architectural innovations (e.g., performer encoders, rank-based encoding) address computational challenges of high-dimensional data, while task-specific designs improve generalizability and interpretability via attention mechanisms.

… resolution, biases from imbalanced pretraining data, and the "black-box" nature of Transformer architectures. High computational costs further hinder accessibility. Future efforts should prioritize multimodal integration of transcriptomic, epigenetic, and spatial data, knowledge-guided architectures incorporating biological networks, efficient few-shot learning frameworks, and lightweight adaptations for greater usability. Addressing these challenges will enhance biological interpretability and bridge AI capabilities with actionable insights, advancing precision medicine and systems biology.

In conclusion, this paper comprehensively examined the applications of LLMs across DNA, RNA, protein, and

↓ Next paragraph was generated here

The highlighted text is near the writing position. This is a layout of the evaluation input, not a PDF screenshot.

A matched comparison at the same writing positionOverall AI review: About the same

Both arms use the same model, task and manuscript context. Only the retrieved passages differ. The first recorded output from each arm is shown below.

Read overall AI review rationale

A = without cards · B = with cards

Both outputs are identical. The sentence continuation 'single-cell domains, highlighting their growing role in sequence analysis, structure prediction, and cellular annotation' appropriately completes the thought by listing the specific biological domains (DNA, RNA, protein, and single-cell) that were introduced in the draft. The continuation is accurate, fits the academic tone, and maintains parallel structure. The mention of 'cellular annotation' for single-cell domain is consistent with the sources discussing single-cell analysis. Since both outputs are identical and equally usable, this is a tie.

Evidence

Same model and position · retrieved passages supplied · first output

single-cell domains, highlighting their growing role in sequence analysis, structure prediction, and cellular annotation.

Passages supplied to the Evidence version

Card 1 · Opportunities for Artificial Intelligence in Advancing Precision Medicine

PURPOSE OF REVIEW: We critically evaluate the future potential of machine learning (ML), deep learning (DL), and artificial intelligence (AI) in precision medicine. The goal of this work is to show progress in ML in digital health, to exemplify future needs and trends, and to identify any essential…

Read full passage excerpt

PURPOSE OF REVIEW: We critically evaluate the future potential of machine learning (ML), deep learning (DL), and artificial intelligence (AI) in precision medicine. The goal of this work is to show progress in ML in digital health, to exemplify future needs and trends, and to identify any essential prerequisites of AI and ML for precision health. RECENT FINDINGS: High-throughput technologies are delivering growing volumes of biomedical data, such as large-scale genome-wide sequencing assays; libraries of medical images; or drug perturbation screens of healthy, developing, and diseased tissue. Multi-omics data in biomedicine is deep and complex, offering an opportunity for data-driven insights and automated disease classification. Learning from these data will open our understanding and definition of healthy baselines and disease signatures. State-of-the-art applications of deep neural networks include digital image recognition, single-cell clustering, and virtual drug screens, demonstr …

Card 2 · Integrative AI-Driven Strategies for Advancing Precision Medicine in Infectious Diseases and Beyond: A Novel Multidisciplinary Approach

Precision medicine, tailored to individual patients based on their genetics, environment, and lifestyle, shows promise in managing complex diseases like infections. Integrating artificial intelligence (AI) into precision medicine can revolutionize disease management. This paper introduces a novel ap…

Read full passage excerpt

Precision medicine, tailored to individual patients based on their genetics, environment, and lifestyle, shows promise in managing complex diseases like infections. Integrating artificial intelligence (AI) into precision medicine can revolutionize disease management. This paper introduces a novel approach using AI to advance precision medicine in infectious diseases and beyond. It integrates diverse fields, analyzing patients' profiles using genomics, proteomics, microbiomics, and clinical data. AI algorithms process vast data, providing insights for precise diagnosis, treatment, and prognosis. AI-driven predictive modeling empowers healthcare providers to make personalized and effective interventions. Collaboration among experts from different domains refines AI models and ensures ethical and robust applications. Beyond infections, this AI-driven approach can benefit other complex diseases. Precision medicine powered by AI has the potential to transform healthcare into a proactive, pa …

Card 3 · A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches

The rapid advancement of high-throughput sequencing and other assay technologies has resulted in the generation of large and complex multi-omics datasets, offering unprecedented opportunities for advancing precision medicine strategies. However, multi-omics data integration presents significant chal…

Read full passage excerpt

The rapid advancement of high-throughput sequencing and other assay technologies has resulted in the generation of large and complex multi-omics datasets, offering unprecedented opportunities for advancing precision medicine strategies. However, multi-omics data integration presents significant challenges due to the high dimensionality, heterogeneity, experimental gaps, and frequency of missing values across data types. Computational methods have been developed to address these issues, employing statistical and machine learning approaches to uncover complex biological patterns and provide deeper insights into our understanding of disease mechanisms. Here, we comprehensively review state-of-the-art multi-omics data integration methods with a focus on deep generative models, particularly variational autoencoders (VAEs) that have been widely used for data imputation and augmentation, joint embedding creation, and batch effect correction. We explore the technical aspects of loss functions …

Card 4 · Deep Learning in Single-Cell and Spatial Transcriptomics Data Analysis: Advances and Challenges from a Data Science Perspective

The development of single-cell and spatial transcriptomics has revolutionized our capacity to investigate cellular properties, functions, and interactions in both cellular and spatial contexts. However, the analysis of single-cell and spatial omics data remains challenging. First, single-cell sequen…

Read full passage excerpt

The development of single-cell and spatial transcriptomics has revolutionized our capacity to investigate cellular properties, functions, and interactions in both cellular and spatial contexts. However, the analysis of single-cell and spatial omics data remains challenging. First, single-cell sequencing data are high-dimensional and sparse, often contaminated by noise and uncertainty, obscuring the underlying biological signals. Second, these data often encompass multiple modalities, including gene expression, epigenetic modifications, and spatial locations. Integrating these diverse data modalities is crucial for enhancing prediction accuracy and biological interpretability. Third, while the scale of single-cell sequencing has expanded to millions of cells, high-quality annotated datasets are still limited. Fourth, the complex correlations of biological tissues make it difficult to accurately reconstruct cellular states and spatial contexts. Traditional feature engineering-based analy …

Card 5 · Multi-omics disease module detection with an explainable Greedy Decision Forest

Machine learning methods can detect complex relationships between variables, but usually do not exploit domain knowledge. This is a limitation because in many scientific disciplines, such as systems biology, domain knowledge is available in the form of graphs or networks, and its use can improve mod…

Read full passage excerpt

Machine learning methods can detect complex relationships between variables, but usually do not exploit domain knowledge. This is a limitation because in many scientific disciplines, such as systems biology, domain knowledge is available in the form of graphs or networks, and its use can improve model performance. We need network-based algorithms that are versatile and applicable in many research areas. In this work, we demonstrate subnetwork detection based on multi-modal node features using a novel Greedy Decision Forest (GDF) with inherent interpretability. The latter will be a crucial factor to retain experts and gain their trust in such algorithms. To demonstrate a concrete application example, we focus on bioinformatics, systems biology and particularly biomedicine, but the presented methodology is applicable in many other domains as well. Systems biology is a good example of a field in which statistical data-driven machine learning enables the analysis of large amounts of multi- …

Model-reported card use

The model did not report that any card materially affected this completion.

No Evidence

Same model and position · no retrieved passages · first output

single-cell domains, highlighting their growing role in sequence analysis, structure prediction, and cellular annotation.

Earlier card-use comparison

The earlier diagnostic compared only cases with reported card use and text on both sides; its scope differs from the overall AI review above.

This case does not have both with-card continuation text and a model-reported use record. It remains among all 280 tests but does not enter the reported-use comparison.

The passages are input material; their presence does not mean an output used them or that they support every claim. Draft and source passages are excerpted; no simulated scores or PDF appear here.